2026.3.16
TCROSS Co., Ltd. announced InsighTCROSS, a solution developed by TCROSS, at its booth in the Business Operations Pavilion of HIMSS 2026, held in Las Vegas from March 10 to 12, 2026. Following a presentation by our CEO, Hashimoto, he was interviewed by Mix Online.
The article highlights "EarlyScripters," which TCROSS introduced to the U.S. market for the first time. EarlyScripters is a solution that analyses physicians' prescribing behavior and attribute data to identify doctors who are likely to adopt new medicines at an early stage. By doing so, it supports pharmaceutical companies in optimizing their marketing strategies and sales activities. The solution also attracted significant attention in the U.S. market as a new approach to enabling data-driven pharmaceutical marketing.
The article was published on 13 March 2026 on Mix Online. Mix is a specialized media outlet that provides professional information on pharmaceutical and healthcare industries through its monthly magazine "Monthly Mix" and its web platform "Mix Online."
Read the article (Japanese) here.
InsighTCROSS® is a decision-support model developed by TCROSS Co., Ltd. for pharmaceutical and medical device companies. By integrating statistical analysis and data science with traditional sales and marketing practices, InsighTCROSS® enables the visualisation of physicians’ prescribing behaviours and decision-making criteria. This approach supports more effective strategy development, allowing companies to optimise resource allocation and reduce marketing costs. Ultimately, InsighTCROSS contributes to more appropriate healthcare spending and the advancement of a sustainable healthcare system.